BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 30514309)

  • 21. PTPN14, a target gene of miR-4295, restricts the growth and invasion of osteosarcoma cells through inactivation of YAP1 signalling.
    Liang G; Duan C; He J; Ma W; Dai X
    Clin Exp Pharmacol Physiol; 2020 Jul; 47(7):1301-1310. PubMed ID: 32141101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CircFAT1 Promotes the Proliferation and Invasion of Malignant Melanoma through miR375-SLC7A11 Signal Axis.
    Lu T; Yang D; Li X
    Anticancer Agents Med Chem; 2023; 23(20):2200-2208. PubMed ID: 37303180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upregulation of miRNA-154-5p prevents the tumorigenesis of osteosarcoma.
    Tian Q; Gu Y; Wang F; Zhou L; Dai Z; Liu H; Wu X; Wang X; Liu Y; Chen S; Han Q
    Biomed Pharmacother; 2020 Apr; 124():109884. PubMed ID: 32000044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long noncoding RNA kcna3 inhibits the progression of colorectal carcinoma through down-regulating YAP1 expression.
    Zhong X; Lü M; Wan J; Zhou T; Qin B
    Biomed Pharmacother; 2018 Nov; 107():382-389. PubMed ID: 30099342
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circular RNA FAT atypical cadherin 1 (circFAT1)/microRNA-525-5p/spindle and kinetochore-associated complex subunit 1 (SKA1) axis regulates oxaliplatin resistance in breast cancer by activating the notch and Wnt signaling pathway.
    Yao Y; Li X; Cheng L; Wu X; Wu B
    Bioengineered; 2021 Dec; 12(1):4032-4043. PubMed ID: 34288822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-363 acts as a tumor suppressor in osteosarcoma cells by inhibiting PDZD2.
    He F; Fang L; Yin Q
    Oncol Rep; 2019 May; 41(5):2729-2738. PubMed ID: 30896877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CircFAT1 Promotes Lung Adenocarcinoma Progression by Sequestering miR-7 from Repressing IRS2-ERK-mediated CCND1 Expression.
    Peng H; Zhang W; Dong H; Yuan J; Li Y; Li F; Yu D; Guan Y; Zhang F
    Int J Biol Sci; 2022; 18(10):3944-3960. PubMed ID: 35844799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CircMYO10 promotes osteosarcoma progression by regulating miR-370-3p/RUVBL1 axis to enhance the transcriptional activity of β-catenin/LEF1 complex via effects on chromatin remodeling.
    Chen J; Liu G; Wu Y; Ma J; Wu H; Xie Z; Chen S; Yang Y; Wang S; Shen P; Fang Y; Fan S; Shen S; Fang X
    Mol Cancer; 2019 Oct; 18(1):150. PubMed ID: 31665067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down-regulation of microRNA-31-5p inhibits proliferation and invasion of osteosarcoma cells through Wnt/β-catenin signaling pathway by enhancing AXIN1.
    Chen X; Zhong L; Li X; Liu W; Zhao Y; Li J
    Exp Mol Pathol; 2019 Jun; 108():32-41. PubMed ID: 30844369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long non-coding RNA PVT1 serves as a competing endogenous RNA for miR-186-5p to promote the tumorigenesis and metastasis of hepatocellular carcinoma.
    Lan T; Yan X; Li Z; Xu X; Mao Q; Ma W; Hong Z; Chen X; Yuan Y
    Tumour Biol; 2017 Jun; 39(6):1010428317705338. PubMed ID: 28656879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MiR-216b inhibits osteosarcoma cell proliferation, migration, and invasion by targeting Forkhead Box M1.
    Wang W; Guo Z; Yu H; Fan L
    J Cell Biochem; 2019 Apr; 120(4):5435-5443. PubMed ID: 30302807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-19a regulates the cell growth and apoptosis of osteosarcoma stem cells by targeting PTEN.
    Zhao D; Chen Y; Chen S; Zheng C; Hu J; Luo S
    Tumour Biol; 2017 May; 39(5):1010428317705341. PubMed ID: 28475001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EIF4A3-induced circular RNA MMP9 (circMMP9) acts as a sponge of miR-124 and promotes glioblastoma multiforme cell tumorigenesis.
    Wang R; Zhang S; Chen X; Li N; Li J; Jia R; Pan Y; Liang H
    Mol Cancer; 2018 Nov; 17(1):166. PubMed ID: 30470262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-451 suppresses proliferation, migration and promotes apoptosis of the human osteosarcoma by targeting macrophage migration inhibitory factor.
    Liu W; Liu SY; He YB; Huang RL; Deng SY; Ni GX; Yu B
    Biomed Pharmacother; 2017 Mar; 87():621-627. PubMed ID: 28086136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hsa_circ_0085576 promotes clear cell renal cell carcinoma tumorigenesis and metastasis through the miR-498/YAP1 axis.
    Liu G; Zhou J; Piao Y; Zhao X; Zuo Y; Ji Z
    Aging (Albany NY); 2020 Jun; 12(12):11530-11549. PubMed ID: 32541093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-137 is downregulated in human osteosarcoma and regulates cell proliferation and migration through targeting FXYD6.
    Li ZM; Zhang HY; Wang YX; Wang WB
    J Drug Target; 2016; 24(2):102-10. PubMed ID: 26302771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Knockdown of YAP1 inhibits the proliferation of osteosarcoma cells in vitro and in vivo.
    Yang Z; Zhang M; Xu K; Liu L; Hou WK; Cai YZ; Xu P; Yao JF
    Oncol Rep; 2014 Sep; 32(3):1265-72. PubMed ID: 24993351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circ-0003998 promotes cell proliferative ability and invasiveness by binding to miR-197-3p in osteosarcoma.
    Wang L; Du ZG; Huang H; Li FS; Li GS; Xu SN
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10638-10646. PubMed ID: 31858530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting of YAP1 by microRNA-15a and microRNA-16-1 exerts tumor suppressor function in gastric adenocarcinoma.
    Kang W; Tong JH; Lung RW; Dong Y; Zhao J; Liang Q; Zhang L; Pan Y; Yang W; Pang JC; Cheng AS; Yu J; To KF
    Mol Cancer; 2015 Feb; 14():52. PubMed ID: 25743273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNA SNHG16 promotes proliferation, migration and invasion of osteosarcoma cells by targeting miR-1301/BCL9 axis.
    Wang X; Hu K; Chao Y; Wang L
    Biomed Pharmacother; 2019 Jun; 114():108798. PubMed ID: 30909141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.